Halozyme Therapeutics Inc. Stock
Halozyme Therapeutics Inc. took a tumble today and lost -€5.130 (-7.680%).
Based on 1 Buy predictions and 2 Sell predictions the sentiment towards Halozyme Therapeutics Inc. is rather balanced.
Based on 1 Buy predictions and 2 Sell predictions the sentiment towards Halozyme Therapeutics Inc. is rather balanced.
Pros and Cons of Halozyme Therapeutics Inc. in the next few years
Pros
?
Brand
?
Shareholder structure
?
Market Position
Cons
?
Growth compared to competition
?
Conscious of the environment
?
Worthwhile Investment for the next years
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Halozyme Therapeutics Inc. vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Halozyme Therapeutics Inc. | -7.680% | -2.236% | -3.208% | 102.708% | 12.097% | - | - |
| Emergent Biosolutions Inc. | -1.250% | -17.526% | -9.091% | 44.144% | 3.896% | 105.444% | 131.683% |
| Alnylam Pharmace. | -0.780% | -3.341% | -16.846% | 9.839% | 12.974% | 22.946% | - |
| Acadia Pharmaceuticals | 0.930% | -3.955% | -9.813% | 7.211% | -7.980% | 60.280% | 134.753% |